University of California, San Francisco
San Francisco, California, 94143, United States
NCT Number: NCT01877876
Evaluation of a new generation of sensors for monitoring blood hemoglobin. The newest version is RevK.
Looking for future studies?
Notify Me18 year–85 year
All sexes
Observational
San Francisco, California, 94143, United States
Evaluation of a new generation of sensors for monitoring blood hemoglobin with the Masimo non-invasive hemoglobin monitor. The newest sensor version is RevK.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Intermittently during spine surgery
Primary outcome is based on the difference between a value from the SpHb (Masimo SpHb™ continuous hemoglobin reading) minus tHb (laboratory hemoglobin determination).
University of California, San Francisco
Other
Assessing the Accuracy of the RevK Sensor for Non-Invasive Hemoglobin Monitoring
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04994704
Patients Undergoing Spine Surgery
Seoul, South Korea
View Trial DetailsNCT01750554
Patients Undergoing Spine Surgery
San Francisco, California, United States
View Trial Details